Form D Explorer

Form D — Addition Therapeutics, Inc.

0002102340-25-000001 · filed Dec 22, 2025

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $28,000,000
Total sold: $28,000,000
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Addition Therapeutics, Inc.
CIK: 2102340
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: 2021
Address: 201 HASKINS WAY, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-430-2889

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Ronald Park · Executive Officer

South San Francisco, CA Find on LinkedIn ↗
Peter Bisgaard · Director

South San Francisco, CA Find on LinkedIn ↗
Kathleen Collins · Director

South San Francisco, CA Find on LinkedIn ↗
Matthew Patterson · Director

South San Francisco, CA Find on LinkedIn ↗
Laetitia Schwab · Director

South San Francisco, CA Find on LinkedIn ↗
Jennifer Lee · Director

South San Francisco, CA Find on LinkedIn ↗
Jayson Punwani · Director

South San Francisco, CA Find on LinkedIn ↗
Lawrence Kong · Executive Officer

South San Francisco, CA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗